Medical/Pharmaceuticals

VISTA Eye Specialist (VISTA), wins 2020 Best Customer Service Award from The Star Outstanding Business Awards (SOBA)

PETALING JAYA, Malaysia, Sept. 28, 2021 /PRNewswire/ -- One of the leading eye specialists inMalaysia, VISTA has been named the winner for Best Customer Service by The SOBA 2020 awards. Chosen amongst hundreds of nominations, the annual awards highlight the nation's best up-and-coming local, smal...

2021-09-28 20:30 3447

BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission

VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...

2021-09-28 20:00 7590

/C O R R E C T I O N -- Oxford Orthopaedics/

We are advised by the client that there are several changes in the release content. The complete, corrected version of the news release issued onSeptember 22, 2021 by Oxford Orthopaedics over PR Newswire is as follows: 1cm "Lasso" Technique for Ankle Ligament Reconstruction, Developed by Drs Tay ...

2021-09-28 19:24 2001

Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India

DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its newDNA/RNA Shield - DirectDetect™ reagent and col...

2021-09-28 14:57 3477

LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research

- Partnership to help decentralize clinical trials resulting in better and faster outcomes MUMBAI, India, Sept. 28, 2021 /PRNewswire/ -- Larsen & Toubro Infotech (BSE: 540005) (NSE: LTI), a global technology consulting and digital solutions company has entered in a...

2021-09-28 14:12 4975

Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

DURHAM, N.C. and BEIJING, Sept. 28, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2021-09-28 08:00 6029

Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions

SAN FRANCISCO and SUZHOU, China and HELLERUP, Denmark, Sept. 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmun...

2021-09-28 08:00 4615

LifeWave Notches Prestigious Inc. 5000 Distinction for the 4th time with Fast Growth and Bold Product Innovation

TOKYO, Sept. 28, 2021 /PRNewswire/ -- Cutting-edge health technology company, LifeWave, has solidified its place as one of America's fastest growing privately held companies by again making theInc. 5000 list for 2021. Released in mid-August, the publication asserts that "brains, bravery, and opti...

2021-09-28 06:46 3888

Ortho Customers Rank Company No. 1 in Service and Support for Sixth Consecutive Year

Company receives top customer rating across six categories in the 2021 IMV ServiceTrak™ Awards RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) today announced that for the sixth consecutive year its Ortho Care™ Service and Support program was ...

2021-09-27 22:00 5608

JW Therapeutics Announces IND Approval for the Clinical Trial of JWCAR129

SHANGHAI, Sept. 27, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced that it has received the Investigational New Drug (IND) clearance from the National Medi...

2021-09-27 20:00 4796

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

* Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in theAtlanta, GA, United States * AIOS is the MDx system that integrates Seegene's liquid handler and real-time PCR instruments. * Seegene MDx system will efficiently access a wide ...

2021-09-27 19:02 3377

GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea

NANJING, China, Sept. 27, 2021 /PRNewswire/ -- EyeGene's mRNA vaccine against COVID-19, namely "EG-COVID", has recently been approved for clinical trials by South Korea's Ministry of Food and Drug Safety (MFDS). GenScript ProBio hereby extended its warm congratulations to the partner. EG-COVID ...

2021-09-27 18:35 3232

Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis

STOCKHOLM, Sept. 27, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that the company's Phase III clinical study of its drug candidate AKP02 for the treatment of psoriasis has been approved by the Indian Medical Products Agency and is ready to start...

2021-09-27 17:37 2048

Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level

SHENZHEN, China, Sept. 27, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading medical solution provider, has launched the new MC-80 Automated Digital Cell Morphology Analyzer, a revolutionary cell morphology system that provides more clarity, more intelligence and more productivity for...

2021-09-27 16:20 5430

Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting

SAN FRANCISCO and SUZHOU, China, Sept. 27, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2021-09-27 08:00 4583

JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)

SHANGHAI, Sept. 26, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced updated 1-year follow-up result of relmacabtagene autoleucel injection (relma-cel) for t...

2021-09-26 20:00 5288

Qiming's Portfolio Company Broncus Lists on Main Board of HKEx

SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Broncus (SEHK:2216),  a pioneer inChina's interventional pulmonology navigation device market, today listed on the main board of Hong Kong Stock Exchange. The issue price isHK$ 18.7/share, representing a market ca...

2021-09-24 14:10 13605

New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA

HONG KONG, Sept. 24, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the National Medical Products Administration (the NMPA) ofChina has officially accepted the new drug application for the world's first-in-class Cadonilimab (PD-1/CTLA-4 bi-specific antibody, research and d...

2021-09-24 14:09 2475

Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206

SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, an...

2021-09-24 13:56 4749

Broncus Lists on Main Board of HKEx

HONG KONG, Sept. 24, 2021 /PRNewswire/ -- On September 24, Broncus (02216.HK), a pioneer in the field of interventional pulmonology inChina, was successfully listed on the main board of the Hong Kong Stock Exchange. Broncus, founded in 2012, is a medical device company focused on the development...

2021-09-24 11:52 6758
1 ... 369370371372373374375 ... 385